Insights on Life Sciences
Article
Closing the women’s health gap: Biopharma’s untapped opportunity
-
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.
Podcast
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
-
Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine, discusses...
Article
Simplification for success: Rewiring the biopharma operating model
-
To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work,...
Podcast
GSK’s Kim Branson on driving innovation with AI and machine learning
-
Pharmaceutical giant GSK’s global head of AI and machine learning describes how these emerging technologies are reshaping...
Article
The transformation imperative: Igniting value creation in medtech
-
Leading medtech companies are embarking on bold transformations and evolving their operating models to unlock sustainable growth...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.
More insights
Article
Faster, smarter trials: Modernizing biopharma’s R&D IT applications
-
To fully realize the potential of AI and digital, biopharma sponsors need a structured approach to upgrading tech infrastructure...
Article
From discovery to delivery: Finding an investment edge in biopharma services
-
Even though the biopharma supply chain is a dynamic and complex part of the pharmaceutical industry, private equity investors...
Article
Gen AI: A game changer for biopharma operations
-
From the shop floor to the supply chain, gen AI can transform how biopharma companies operate. Four use cases show how it can...
Article
How medtech companies can create value via inventory optimization
-
With more efficient inventory management, medtechs can reduce inventory by up to 30 percent—freeing up cash and reducing...
Article
Scaling gen AI in the life sciences industry
-
Gen AI pilots have shown promise, but for the technology to deliver transformational business value in the life sciences industry,...
Article
Strengthening the R&D operating model for pharmaceutical companies
-
Revisiting the operating model could help pharmaceutical companies improve R&D productivity.
Article
How biopharmaceutical leaders optimize their portfolio strategies
-
Leading biopharmaceutical companies manage their clinical pipelines to optimize for risk and reward. Here’s how.
Article
Building a shared vision for pharma R&D–supplier partnerships
-
Pharma R&D leaders and their suppliers see transparency as a key to unlocking more effective collaborations and cost efficiencies....
Article
Charting the path to patients
-
Careful development of asset strategy across the pharmaceutical R&D pipeline is increasingly important in embracing opportunities...
Article
Boosting biopharma R&D performance with a next-generation technology stack
-
A modern, well-designed tech stack can unlock the potential of AI, automation, and data and their promised benefits to R&D...
Article
Putting people at the center of the R&D talent model in life sciences
-
Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D...